The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Advanced glycation end products and the kidney
Abstract
Advanced glycation end products (AGEs) are a heterogeneous group of protein and lipids to which sugar residues are covalently bound. AGE formation is increased in situations with hyperglycemia (e.g., diabetes mellitus) and is also stimulated by oxidative stress, for example in uremia. It appears that activation of the renin-angiotensin system may contribute to AGE formation through various mechanisms. Although AGEs could nonspecifically bind to basement membranes and modify their properties, they also induce specific cellular responses including the release of profibrogenic and proinflammatory cytokines by interacting with the receptor for AGE (RAGE). However, additional receptors could bind AGEs, adding to the complexity of this system. The kidney is both: culprit and target of AGEs. A decrease in renal function increases circulating AGE concentrations by reduced clearance as well as increased formation. On the other hand, AGEs are involved in the structural changes of progressive nephropathies such as glomerulosclerosis, interstitial fibrosis, and tubular atrophy. These effects are most prominent in diabetic nephropathy, but they also contribute to renal pathophysiology in other nondiabetic renal diseases. Interference with AGE formation has therapeutic potential for preventing the progression of chronic renal diseases, as shown from data of animal experiments and, more recently, the first clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., & Clauss, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., & Baynes, J. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116481 · Cited by 769
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 727
YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Aronson, D. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00002 · Cited by 651
Huttunen, H. J., Fages, C., & Rauvala, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19919 · Cited by 628
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Self-citationZiyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Self-citationThe Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030800 · Cited by 582
Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & De Caterina, R. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
TANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Cooper, M. E., Vranes, D., Youssef, S., Stacker, S. A., Cox, A. J., Rizkalla, B., Casley, D. J., Bach, L. A., Kelly, D. J., & Gilbert, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2229 · Cited by 474
Oldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. C., Osicka, T., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 472
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Wautier, J.-L., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 436
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S. P., Poitevin, P., Swennen, G. N. M., Vasan, S., Egan, J. J., Ulrich, P., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433 · cited 1×
“Horie and colleagues (53) examined in detail the immunohistochemical localization of glycoxidation products in glomerular lesions and in the vasculature of patients with early compared with advanced diabetic nephropathy.”
BackgroundTanaka, N., Yonekura, H., Yamagishi, S.-I., Fujimori, H., Yamamoto, Y., & Yamamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001235200 · Cited by 424
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Anderson, M. M., Hazen, S. L., Hsu, F. F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 389
Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules
Roth, J., Vogl, T., Sorg, C., & Sunderkötter, C. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00062-0 · Cited by 388
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 367
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β
Wolf, G., Sharma, K., Chen, Y., Ericksen, M., & Ziyadeh, F. N. (1992) · Kidney International · doi:10.1038/ki.1992.330 · Cited by 356
Self-citationSchrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0018 · Cited by 353
Miyata, T., Wada, Y., Cai, Z., Iida, Y., Horie, K., Yasuda, Y., Maeda, K., Kurokawa, K., & De Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.160 · Cited by 352
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Li, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 341
Yeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1495 · Cited by 326
Yamagishi, S.-I., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 310
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Glycation Induces Formation of Amyloid Cross-β Structure in Albumin
Bouma, B., Kroon-Batenburg, L. M. J., Wu, Y.-P., Brünjes, B., Posthuma, G., Kranenburg, O., de Groot, P. G., Voest, E. E., & Gebbink, M. F. B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303925200 · Cited by 286
Miyata, T., Hori, O., Zhang, J., Yan, S. D., Ferran, L., Iida, Y., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118889 · Cited by 285
Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., & Maeda, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0221 · Cited by 284
Arumugam, T., Simeone, D. M., Schmidt, A. M., & Logsdon, C. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310124200 · Cited by 267
Forbes, J. M., Thallas, V., Thomas, M. C., Founds, H. W., Burns, W. C., Jerums, G., & Cooper, M. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-1102fje · Cited by 263
Giardino, I., Edelstein, D., & Brownlee, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118563 · Cited by 258
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Sugaya, K., Fukagawa, T., Matsumoto, K.-I., Mita, K., Takahashi, E.-I., Ando, A., Inoko, H., & Ikemura, T. (1994) · Genomics · doi:10.1006/geno.1994.1517 · Cited by 242
Jain, S. K., & Lim, G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00462-7 · Cited by 242
Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Lu, C., He, J. C., Cai, W., Liu, H., Zhu, L., & Vlassara, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401588101 · Cited by 228
Renal catabolism of advanced glycation end products: the fate of pentosidine
Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00756.x · Cited by 227 · cited 2×
“After being filtered into the urine, small AGE molecules may undergo further degradation and modification while being reabsorbed partly by proximal tubular cells (9, 80).”
BackgroundSoulis, T., Thallas, V., Youssef, S., Gilbert, R. E., McWilliam, B. G., Cooper, M. E., & Murray-McIntosh, R. P. (1997) · Diabetologia · doi:10.1007/s001250050725 · Cited by 222
AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction
Fukami, K., Ueda, S., Yamagishi, S.-I., Kato, S., Inagaki, Y., Takeuchi, M., Motomiya, Y., Bucala, R., Iida, S., Tamaki, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66004.x · Cited by 218
Li, J. H., Wang, W., Huang, X. R., Oldfield, M., Schmidt, A. M., Cooper, M. E., & Lan, H. Y. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63225-7 · Cited by 217
BAKRIS, G., BANK, A., KASS, D., NEUTEL, J., PRESTON, R., & OPARIL, S. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.022 · Cited by 210
MIYATA, T., KUROKAWA, K., & VAN YPERSELE DE STRIHOU, C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191744 · Cited by 207
Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N., & Takei, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119285 · Cited by 196
Haitoglou, C. S., Tsilibary, E. C., Brownlee, M., & Charonis, A. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42287-9 · Cited by 195
Shanmugam, N., Kim, Y. S., Lanting, L., & Natarajan, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302828200 · Cited by 192
Metz, T. O., Alderson, N. L., Thorpe, S. R., & Baynes, J. W. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.021 · Cited by 191
Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
PUGLIESE, G., PRICCI, F., IACOBINI, C., LETO, G., AMADIO, L., BARSOTTI, P., FRIGERI, L., HSU, D. K., VLASSARA, H., LIU, F.-T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 184
Schiekofer, S., Andrassy, M., Chen, J., Rudofsky, G., Schneider, J., Wendt, T., Stefan, N., Humpert, P., Fritsche, A., Stumvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.621 · Cited by 180
Cai, W., He, J. C., Zhu, L., Peppa, M., Lu, C., Uribarri, J., & Vlassara, H. (2004) · Circulation · doi:10.1161/01.cir.0000135587.92455.0d · Cited by 177
Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury
Zhou, Z., Wang, K., Penn, M. S., Marso, S. P., Lauer, M. A., Forudi, F., Zhou, X., Qu, W., Lu, Y., Stern, D. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000063577.32819.23 · Cited by 173
Nangaku, M., Miyata, T., Sada, T., Mizuno, M., Inagi, R., Ueda, Y., Ishikawa, N., Yuzawa, H., Koike, H., van Ypersele de Strihou, C., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000062961.76776.c1 · Cited by 173
Alderson, N. L., Chachich, M. E., Youssef, N. N., Beattie, R. J., Nachtigal, M., Thorpe, S. R., & Baynes, J. W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00027.x · Cited by 171
Cell cycle regulation in diabetic nephropathy
Wolf, G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07710.x · Cited by 171
Self-citationNonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Mott, J. D., Khalifah, R. G., Nagase, H., Shield, C. F., Hudson, J. K., & Hudson, B. G. (1997) · Kidney International · doi:10.1038/ki.1997.455 · Cited by 170
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Morcos, M., Sayed, A. A. R., Bierhaus, A., Yard, B. A., Waldherr, R., Merz, W. E., Klöting, I., Schleicher, E. D., Mentz, S., Baki, R. A. E., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3532 · Cited by 169
Yamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., & Takeuchi, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00752.x · Cited by 165
Zhou, G., Li, C., & Cai, L. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63254-3 · Cited by 164
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., Van Ypersele de Strihou, C., & Kurokawa, K. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991681 · Cited by 162
Miyata, T., Fu, M.-X., Kurokawa, K., de Strihou, C. V. Y., Thorpe, S. R., & Baynes, J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00093.x · Cited by 161
Renoprotective effects of a novel inhibitor of advanced glycation
Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G., & Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250051587 · Cited by 161
Malherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., & Huber, G. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00174-6 · Cited by 156
Hudson, B. I., Stickland, M. H., & Grant, P. J. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1155 · Cited by 153
Ahmed, N., & Thornalley, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311417 · Cited by 152
Thallas‐Bonke, V., Lindschau, C., Rizkalla, B., Bach, L. A., Boner, G., Meier, M., Haller, H. G., Cooper, M. E., & Forbes, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2921 · Cited by 151
Lassila, M., Seah, K. K., Allen, T. J., Thallas, V., Thomas, M. C., Candido, R., Burns, W. C., Forbes, J. M., Calkin, A. C., Cooper, M. E., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133025.23732.46 · Cited by 148
Cohen, M. P., Sharma, K., Jin, Y. S., Hud, E., Wu, V.-Y., Tomaszewski, J., & Ziyadeh, F. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117926 · Cited by 148
Twigg, S. M., Cao, Z., McLennan, S., Burns, W. C., Brammar, G. C., Forbes, J. M., & Cooper, M. E. (2002) · Endocrinology · doi:10.1210/en.2002-220619 · Cited by 143
Modification of Proteins In Vitro by Physiological Levels of Glucose
Voziyan, P., Khalifah, R. G., Thibaudeau, C., Yıldız, A., Jacob, J., Serianni, A. S., & Hudson, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307155200 · Cited by 143
Nagai, R., Unno, Y., Hayashi, M. C., Masuda, S., Hayase, F., Kinae, N., & Horiuchi, S. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2833 · Cited by 142
Simon, M., Röckl, W., Hornig, C., Gröne, E., Theis, H., Weich, H. A., Fuchs, E., Yayon, A., & Gröne, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961032 · Cited by 141
CD36, serves as a receptor for advanced glycation endproducts (AGE)
Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Miyazaki, A., Hakamata, H., Horiuchi, S., & Nakayama, H. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00208-2 · Cited by 140
Sorci, G., Riuzzi, F., Arcuri, C., Giambanco, I., & Donato, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4880-4894.2004 · Cited by 138
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., Caterina, R. D., Basta, G., Wautier, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2662 · Cited by 136
Busch, M., Franke, S., Müller, A., Wolf, M., Gerth, J., Ott, U., Niwa, T., & Stein, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00736.x · Cited by 136
Self-citationMiyata, T., Ueda, Y., Yoshida, A., Sugiyama, S., Iida, Y., Jadoul, M. Y., Maeda, K., Kurokawa, K., & de Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.124 · Cited by 131
High Human Renin Hypertension in Transgenic Rats
Bohlender, J. M., Fukamizu, A., Lippoldt, A., Nomura, T., Dietz, R., Ménard, J., Murakami, K., Luft, F. C., & Ganten, D. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.428 · Cited by 130
Self-citationKelly, D. J., Gilbert, R. E., Cox, A. J., Soulis, T., Jerums, G., & Cooper, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102098 · Cited by 128
Henle, T., Deppisch, R. M., Beck, W., Hergesell, O., Hänsch, G. M., & Ritz, E. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.8.1968 · Cited by 127
Rashid, G., Benchetrit, S., Fishman, D., & Bernheim, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00860.x · Cited by 116
Hein, G. E. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg324 · Cited by 114
Scavenger Receptors that Recognize Advanced Glycation End Products
Miyazaki, A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00171-8 · Cited by 113
Stitt, A. W., He, C., & Vlassara, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0291 · Cited by 113
Chen, S., Cohen, M. P., Lautenslager, G. T., Shearman, C. W., & Ziyadeh, F. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002673.x · Cited by 113
Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in Vivo
Metz, T., Alderson, N. L., Chachich, M. E., Thorpe, S. R., & Baynes, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304292200 · Cited by 112
Genotoxicity of advanced glycation end products in mammalian cells
Stopper, H., Schinzel, R., Šebeková, K., & Heidland, A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00626-2 · Cited by 111
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
Role of galectin-3 in diabetic nephropathy
Iacobini, C., Amadio, L., Oddi, G., Ricci, C., Barsotti, P., Missori, S., Sorcini, M., Di Mario, U., Pricci, F., & Pugliese, G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077402.95720.b4 · Cited by 99 · cited 1×
“The molecule obviously exerts protective cellular effects with an aim to modulate or to contain AGE-dependent inflammatory or noxious reactions (57, 147).”
BackgroundGeoffroy, K., Wiernsperger, N. F., Lagarde, M., & Bawab, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403273200 · Cited by 97
Miyata, T., Ueda, Y., Asahi, K., Izuhara, Y., Inagi, R., Saitō, A., de Strihou, C. V. Y., & Kurokawa, K. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191719 · Cited by 90
Agarwal, R., Campbell, R. C., & Warnock, D. G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2003.11.008 · Cited by 89
Level of an Advanced Glycated End Product Is Genetically Determined
Leslie, R. D., Beyan, H., Sawtell, P., Boehm, B. O., Spector, T. D., & Snieder, H. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2441 · Cited by 88
He, C., Zheng, F., Stitt, A. W., Striker, L. J., Hattori, M., & Vlassara, H. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00365.x · Cited by 83
Expression of receptors for advanced glycosylated end-products in renal disease
Abel, M., Ritthaler, U., Zhang, Y., Deng, Y., Schmidt, A. M., Greten, H. J., Sernau, T., Wahl, P. R., Andrássy, K., Ritz, E., et al. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.9.1662 · Cited by 83
Shaw, S., Schmidt, A. M., Banes, A. K., Wang, X., Stern, D. M., & Marrero, M. B. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2381 · Cited by 83
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding
Youssef, S., Nguyen, D. T., Soulis, T., Panagiotopoulos, S., Jerums, G., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003907.x · Cited by 74
Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis
Takahashi, M., Suzuki, M., KUSHIDA, K., et al. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.6.637 · Cited by 73
Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H., & Bucala, R. (2001) · Molecular Medicine · doi:10.1007/bf03401963 · Cited by 70
Human mesangial cells express inducible macrophage scavenger receptor
Ruan, X. Z., Varghese, Z., Powis, S. H., & Moorhead, J. F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00587.x · Cited by 69
Xu, D., & Kyriakis, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302771200 · Cited by 64
Crosslink breakers: a new approach to cardiovascular therapy
Sušić, D., Varagić, J., Ahn, J., & Frohlich, E. D. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000127135.73849.4f · Cited by 63
Inhibitory Effects of Tenilsetam on the Maillard Reaction
Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 61
Šebeková, K., Gazdíková, K., Syrova, D., et al. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001541 · Cited by 60
Biomechanical properties and chemical composition of the aorta in genetic hypertensive rats
Mizutani, K., Ikeda, K., Kawai, Y., & Yamori, Y. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00005 · Cited by 58
Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells
Cohen, M. P., Ziyadeh, F. N., Lautenslager, G. T., et al. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f684 · Cited by 57
Brizzi, M. F., Dentelli, P., Rosso, A., Calvi, C., Gambino, R., Cassader, M., Salvidio, G., Deferrari, G., Camussi, G., Pegoraro, L., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1053fje · Cited by 56
Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease
Falcone, C., Campo, I., Emanuele, E., Buzzi, M. P., Zorzetto, M., Sbarsi, I., & Cuccia, M. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.6.1061 · Cited by 55
Paradoxical Impact of Antioxidants on Post-Amadori Glycoxidation
Culbertson, S. M., Vassilenko, E. I., Morrison, L. D., & Ingold, K. U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305099200 · Cited by 52
Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease
Williams, M. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0054-0 · Cited by 48
Role of Megalin in Endocytosis of Advanced Glycation End Products
Saito, A., Nagai, R., Tanuma, A., Hama, H., Cho, K., Takeda, T., Yoshida, Y., Toda, T., Shimizu, F., Horiuchi, S., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000062962.51879.f8 · Cited by 48
Glycation of human serum albumin: inhibition by Diclofenac
van Boekel, M. A. M., van den Bergh, P. J. P. C., & Hoenders, H. J. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90270-n · Cited by 46
Gugliucci, A., & Bendayan, M. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.6.7769229 · Cited by 45
Mené, P., Pascale, C., Teti, A. M., BERNARDINI, S., Cinotti, G. A., & Pugliese, F. R. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071478 · Cited by 42
Ueda, Y., Miyata, T., Hashimoto, T., Yamada, H., Izuhara, Y., Sakai, H., & Kurokawa, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8523 · Cited by 40
Inhibiting Albumin Glycation Ameliorates Diabetic Nephropathy in the db/db Mouse
Cohen, M. P., Masson, N., Hud, E., Ziyadeh, F. N., Han, D. C., & Clements, R. S. (2000) · Nephron Experimental Nephrology · doi:10.1159/000020661 · Cited by 39
Forbes, J. M., Thomas, M. C., Thorpe, S. R., Alderson, N. L., & Cooper, M. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09225.x · Cited by 37
Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats
Oturai, P., Christensen, M., Rolin, B., et al. (2000) · Metabolism · doi:10.1053/meta.2000.7731 · Cited by 34
Matrix protein glycation impairs agonist‐induced intracellular Ca2+ signaling in endothelial cells
Bishara, N. B., Dunlop, M., Murphy, T. V., Darby, I. A., Rajanayagam, M. A. S., & Hill, M. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10153 · Cited by 33
Renal Proximal Tubular Metabolism of Protein-Linked Pentosidine, an Advanced Glycation End Product
Asano, M., Fujita, Y., Ueda, Y., Suzuki, D., Miyata, T., Sakai, H., & Saitō, A. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000065032 · Cited by 31
Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1
Cohen, M. P., Ziyadeh, F. N., Hong, S. W., Shearman, C. W., Hud, E., Lautenslager, G. T., de la Cruz, M. D. C. I., & Chen, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00352.x · Cited by 31
Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Stein, G., Busch, M., Müller, A. M. F., Wendt, T., Franke, C., Niwa, T., & Franke, S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50085 · Cited by 27
Self-citationAscorbic acid, glycation, glycohemoglobin and aging
Krone, C. A., & Ely, J. T. A. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00313-x · Cited by 21
Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus
Men�, P., Festuccia, F., & Pugliese, F. R. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303050-00002 · Cited by 18
Nakamura, S., Tachikawa, T., Tobita, K., Aoyama, I., Takayama, F., Enomoto, A., & Niwa, T. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50088 · Cited by 18
Hudson, B. I., Stickland, M. H., Futers, T. S., & Grant, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.2004 · Cited by 17
Lin, Y.-T., Tseng, Y., & Chang, K. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901008 · Cited by 15
Deuther‐Conrad, W., Franke, S., Sommer, M., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.07815.x · Cited by 10
Self-citation
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Immune cell dysfunction and inflammation in end-stage renal disease
Betjes, M. G. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.44 · Cited by 542
Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease
van der Veen, B. S., de Winther, M. P. J., & Heeringa, P. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2538 · Cited by 518
Metadata
- Authors
- Bohlender, J. M., Franke, S., Stein, G., & Wolf, G.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2005-10
- Volume
- 289
- Issue
- 4
- Pages
- F645-F659
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2126728583
- Cited by
- 387
- References
- 157
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.